Articles for Beginners Five Advantages of Taking KarXT (Cobenfy)/ A Summary Article for Beginners
Introduction A new antipsychotic drug called KarXT (Cobenfy) was recently approved by the FDA. In the U.S., it will be l...
Articles for Beginners 
Muscarinic Agonists 【NBI-1117568】Detailed analysis of Phase 2 results data/More effective than olanzapine
Introduction The results of the Phase 2 study of NBI-1117568 are now available. I will discuss the resulting data. The r...
Important Articles 21 Drugs for Cognitive and Negative Symptoms of Schizophrenia in 2024 【Revised 2024.5.20】
Introduction This article summarizes new drugs in development that may help with cognitive dysfunction and negative symp...
Muscarinic Agonists KarXT(Cobenfy) has a high long-term efficacy/ Long-term study results/EMERGENT-4
Introduction The results of a long-term study of KarXT(Cobenfy) were recently published, and I thought the long-term eff...
Important Articles List of antipsychotics under development in 2024【Revised 2024.1.26】
Introduction I'll do as much research as I can about the antipsychotics in development in the list below, and I'll write...
Investigational Drugs Brilaroxazine/High Efficacy & Mild Side Effects
Introduction In October 2023, the results of a Phase 3 study of brilaroxazine were announced. Brilaroxazine is an antips...
Articles for Beginners Innovative Schizophrenia Drugs【Summary part 2】Ulotaront, etc.
Introduction （This article is a translation of an article for Japanese readers.） In this article, following on from (par...
Ulotaront 【Ulotaront】U.S. Phase 3 Studies Failed. What’s Next? / Clinical Trial Data
Introduction The results of the Phase 3 trials of Ulotaront were released in July 2023. Two Phase 3 trials were both fai...
Articles for Beginners Innovative Schizophrenia Drugs【Summary part 1】Muscarinic Agonists
Introduction In this article and the next, I will summarize innovative schizophrenia drugs that will be released in the ...
Muscarinic Agonists EMERGENT-3【KarXT(Cobenfy)】Efficacy Compared to Current Drugs in Phase3
Introduction Now that the results of KarXT(Cobenfy)'s second Phase 3 trial are in, I have a lot to think about. This tri...
Ulotaront A lot of benefits of taking【Ulotaront】: A new antipsychotic drug
Introduction Ulotaront acts as a TAAR1 agonist and a 5HT1A receptor agonist. I found a review article that describes the...
Ulotaront 【Ulotaront part 2】Phase 2 trial was successful. / Clinical Trial Data
Introduction In Part2, I will write about the efficacy of Ulotaront, one of the most anticipated antipsychotic drugs of ...
Ulotaront 【Ulotaront part 1】Promising TAAR1 agonist
Introduction I have written several times that I am most excited about muscarinic agonists such as KarXT, Emraclidine, a...
Important Articles Positive and Negative Syndrome Scale(PANSS, Scale used to measure efficacy)
Introduction What is PANSS? PANSS (Positive and Negative Syndrome Scale) is a scale used to measure the severity of schi...
Important Articles About this blog
In this blog, I will try to provide the world with the latest information on "psychotropic drugs under development" and ...